20.69
+2.84(+15.91%)
Currency In USD
| Previous Close | 17.85 |
| Open | 17.83 |
| Day High | 21.18 |
| Day Low | 16.4 |
| 52-Week High | 21.18 |
| 52-Week Low | 2.88 |
| Volume | 1.88M |
| Average Volume | 556,493 |
| Market Cap | 741.84M |
| PE | 1.52 |
| EPS | 13.61 |
| Moving Average 50 Days | 10.83 |
| Moving Average 200 Days | 6.15 |
| Change | 2.84 |
If you invested $1000 in BioAge Labs, Inc. (BIOA) since IPO date, it would be worth $1,129.98 as of January 14, 2026 at a share price of $20.69. Whereas If you bought $1000 worth of BioAge Labs, Inc. (BIOA) shares 1 year ago, it would be worth $4,459.05 as of January 14, 2026 at a share price of $20.69.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP Reduction in Participants with Elevated Cardiovascular Risk
GlobeNewswire Inc.
Jan 12, 2026 2:00 PM GMT
First BGE-102 MAD cohort completed in obese individuals with elevated hsCRP receiving 120 mg QD; demonstrated rapid and profound reduction in inflammatory markers BGE-102 achieved 86% reduction in hsCRP at Day 14, with 93% of participants reaching no
BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
GlobeNewswire Inc.
Dec 04, 2025 2:00 PM GMT
BGE-102 was well-tolerated in SAD and initial MAD cohorts, with a pharmacokinetic profile supporting once-daily oral dosing Strong target engagement: BGE-102 achieved 90-98% suppression of IL-1β, a cytokine directly downstream of NLRP3, at Day 14 Hig
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 25, 2025 9:30 PM GMT
EMERYVILLE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of hu